FINWIRES · TerminalLIVE
FINWIRES

Pfizer Reaches Three Settlements in Vyndamax Patent Infringement Suits

By

-- Pfizer (PFE) said Tuesday it entered into settlement agreements with three generic drug manufacturers regarding lawsuits filed in the US District Court for the District of Delaware for patent infringement related to Vyndamax, a cardiomyopathy transthyretin-mediated amyloidosis treatment.

The settlements extend the drug's effective US patent expiry date to June 1, 2031, subject to the outcome of other litigation, the company said.

"Pfizer had previously anticipated a significant decline in U.S. revenues for Vyndamax beginning in 2029 upon patent expiry," Pfizer said. "As a result of this settlement, revenues are now expected to remain relatively stable from 2028 through mid-2031."

Price: $26.65, Change: $-0.15, Percent Change: -0.54%

Related Articles

Australia

Velo3D Closes $50 Million Registered Direct Offering

Velo3D (VELO) said Tuesday it closed an underwritten registered direct offering of nearly 3.6 million common shares for gross proceeds of about $50 million.Net proceeds will be used for working capital and general corporate purposes, the company added.Price: $13.76, Change: $-0.57, Percent Change: -3.98%

$VELO
Australia

First Financial Bankshares Ups Quarterly Dividend 15.8% to $0.22 a Share, Payable July 1 to Holders of Record June 12

Price: $32.61, Change: $+0.18, Percent Change: +0.56%

$FFIN
Mining & Metals

First Atlas Resources Sells MacKenzie East Claims in Quebec to LaFleur Minerals

First Atlas Resources (HHE.CN) on Tuesday said it agreed to sell a 100% interest in its MacKenzie East Claims located in the Val-d'Or gold camp, Quebec, to LaFleur Minerals (LFLR.CN) in a cash and stock deal.LaFleur will buy the property in exchange for $30,000 in cash, and 175,000 shares of LaFleur Minerals. The cash portion is payable within 48 hours of execution of the agreement, the company said.The share consideration will be issued upon receipt of exchange acceptance or, if not required, within five business days following closing of the deal. The property consists of 46 mineral claims covering about 1,781 hectares.The deal allows First Atlas to monetize a non-core asset while retaining exposure to the upside of the Val-d'Or region through its equity interest in LaFleur, it added.Shares of First Atlas were last seen down $0.005 to $0.10 on the Canadian Securities Exchange.

$HHE.CN$LFLR.CN